2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...
The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.
Less than two years after emerging, Arena BioWorks is shuttering, citing the “adverse impact of biotech macro conditions” as ...
The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...
iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...
Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...
XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...
For decades, women’s health has struggled with gaps in research and a lack of tools designed specifically for female biology. Hormone testing, in particular, has often left women with raw numbers and ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Just north of San Francisco International Airport lies one of the densest clusters of biotechnology companies in the world. The neighborhoods along Brisbane’s and South San Francisco’s eastern ...